Trials / Completed
CompletedNCT00365248
TachoSil Paediatric Liver Trial (TC-019-IN)
A Prospective, Multi-centre Phase III-b Study of TachoSil in Paediatric Patients Scheduled for Resection of the Liver With or Without Segmental Liver Transplantation.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 4 Weeks – 6 Years
- Healthy volunteers
- Not accepted
Summary
The overall objective is to assess the haemostatic efficacy and safety of TachoSil for control of local bleeding in paediatric patients undergoing surgical resection of the liver with our without segmental liver transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fibrinogen human (TachoSil) | Resection of the liver with or without segmental liver transplantation |
Timeline
- Start date
- 2005-10-01
- Completion
- 2008-05-01
- First posted
- 2006-08-17
- Last updated
- 2012-05-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00365248. Inclusion in this directory is not an endorsement.